More generic M&A action: The Israeli generics giant Teva is in talks to buy Barr Pharmaceuticals, a U.S. generics shop with market cap of about $5 billion, the Israeli business paper Globes reported.
Barr’s stock shot up nearly 20% in after-hours trading on the report.
While the branded drug industry has been ailing, the generics business has [...]
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment